Synuclein is a protein that is found in abundance in neurons and is particularly enriched in presynaptic nerve terminals. Synaptic vesicle trafficking and ensuing neurotransmitter release are controlled by -synuclein. -synuclein has been linked to Parkinson's disease (PD) and other neurodegenerative diseases through genetic and neuropathology research. Multiple neurodegenerative diseases known as synucleinopathies are characterized by the accumulation of misfolded oligomers and larger aggregates of -synuclein, but the mechanisms by which -synuclein acts in neurodegeneration are unknown.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V70176 | (Rac)-Minzasolmin ((Rac)-UCB0599; NPT200-11) | 1802518-63-3 | (Rac)-Minzasolmin ((Rac)-UCB0599) is a brain barrier-penetrating inhibitor that can suppress the accumulation of alpha-synuclein (ASYN) misfolding and aggregation. |
|
V70190 | (S)-Minzasolmin ((S)-UCB0599; (S)-NPT200-11) | 1802518-91-7 | (S)-Minzasolmin is an enantiomer of Minzasolmin, an inhibitor (blocker/antagonist) of α-synuclein oligomerization. |
|
V109175 | 1-Aminoindan | 34698-41-4 | 1-Aminoindene (1-indeneamine) is a metabolite of rasagiline. |
|
V124806 | 2N4R Tau/α-Syn against-1 | 2N4R Tau/α-Syn inhibitor-1 (compound 4d) targets α-synuclein and tau protein, inhibiting their fibrillation and oligomerization, and exhibits depolymerization activity against Aβ filaments. | |
|
V112669 | Alpinin A | 2151847-03-7 | Galangin A is a diarylheptane compound found in the rhizomes of galangal (Alpinia officinarum). |
|
V108926 | Arg-PEG1-Tαsyn | Arg-PEG1-Tαsyn is a PROTAC degrader targeting α-synuclein, with a median lethal concentration (DC50) of 0.28 μM in U251 cells. | |
|
V80156 | Brazilin-7-acetate | Brazilin-7-acetate (B-7-A) is an inhibitor (blocker/antagonist) of α-synuclein (α-Syn) aggregates. | |
|
V70194 | D-685 | 2893801-00-6 | D-685, a prodrug of D-520, displays greater in vivo anti-PD/Parkinson's disease efficacy than parent D-520 in a lipidated animal model of PD/Parkinson's disease. |
|
V94863 | GSD-16-24 | GSD-16-24 is a lead compound that binds directly to the C-terminal IDR of α-syn monomers and fibrils, thereby preventing fibrils from binding to the receptor. | |
|
V137639 | HUP-46 | 3007689-83-7 | HUP-46 is an α-synuclein dimer and autophagy regulator that can cross the blood-brain barrier. |
|
V138338 | KAC-50.1 | KAC-50.1 is an α-synuclein (α-syn) PET ligand with a KD of 35 nM for site 2 in recombinant α-syn fibrils. | |
|
V87865 | LETC | LETC is an orally active inhibitor of α-synuclein (α-Syn) aggregation with an EC50 of 66 nM in transfected DH60.21 neuroblastoma cells. | |
|
V70179 | Minzasolmin (UCB0599; (R)-NPT200-11) | 1802518-92-8 | Minzasolmin is an inhibitor (blocker/antagonist) of alpha-synuclein oligomerization. |
|
V120388 | MK-7337 | 3056154-69-6 | MK-7337 is a PET ligand for α-synuclein. |
|
V140097 | MNP2 | MNP2 is an inhibitor of NLRP3-ASC interaction. | |
|
V116748 | Movronersen | 2411937-33-0 | Movronersen is an antisense oligonucleotide that targets α-synuclein. |
|
|
V116768 | Movronersen sodium | Movronersen sodium is an antisense oligonucleotide that targets α-synuclein. | |
|
V140205 | Movronersen sodium scrambled negative control | The Movronersen sodium scrambled negative control is a negative control with the sequence of Movronersen sodium scrambled. | |
|
V3222 | ELN484228 | 312-63-0 | ELN484228, a phenyl-sulfonamide compound, is a cell-permeable blocker ofα-synucleinwhich is a key protein in Parkinson’s disease. |
|
V112289 | NPT100-18A | NPT100-18A is an inhibitor of α-synuclein oligomerization. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
